Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Journal of Infectious Diseases

• Publication date

  1985-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/INFDIS/152.5.1083PMID 4045247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Giant cell pneumonia due to respiratory syncytial virus.

  1985cited by this paper
• Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus.

  1984cited by this paper
• Mechanisms of immunity to respiratory syncytial virus in cotton rats

  1983cited by this paper
• Measurement of monoclonal antibody concentrations in hybridoma cultures: comparison of competitive inhibition and antigen capture enzyme immunoassays.

  1983cited by this paper
• Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses

  1981cited by this paper
• Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level.

  1981cited by this paper
• Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants

  1979cited by this paper
• Respiratory syncytial virus in early infancy. Circulating antibody and the severity of infection.

  1977cited by this paper
• Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus.

  1976cited by this paper
• Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness.

  1971cited by this paper
• Influence of immunological factors in respiratory syncytial virus disease.

  1970cited by this paper
• An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.

  1969cited by this paper

• Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine

  2023cites this paper
• Antibody effector functions are associated with protection from respiratory syncytial virus.

  2022cites this paper
• Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections

  2021cites this paper
• Passive immunization

  2020cites this paper
• Uncovering axes of variation among single-cell cancer specimens

  2020cites this paper
• CellTagging: combinatorial indexing to simultaneously map lineage and identity at single-cell resolution

  2020cites this paper
• High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects

  2020cites this paper
• RESHAPING A HUMAN MONOCLONAL ANTIBODY TO INHIBIT HUMAN RESPIRATORY SYNcmAI . VIRUS INFEOION IN VNO

  2017cites this paper
• Recent Advances in Developing Antiviral Therapies for Respiratory Syncytial Virus

  2017cites this paper
• Passive Immunization

  2017cites this paper
• Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role

  2017cites this paper
• Animal models of respiratory syncytial virus infection

  2017cites this paper
• Evaluation of Nitrogen Levels and Methanol Spraying on The Yield, Yield Components and Catalase Activities of Sugar Beet in Karaj and Moghan Region

  2016cites this paper
• Revealing the binding mode between respiratory syncytial virus fusion protein and benzimidazole-based inhibitors.

  2015cites this paper
• Prevention of Respiratory Syncytial Virus Infection: From Vaccine to Antibody

  2014cites this paper
• Respiratory syncytial virus: current and emerging treatment options

  2014cites this paper
• Viral infection of the lung: Host response and sequelae

  2013cites this paper
• Clinical reviews in allergy and immunology

  2012cites this paper
• Treatment of Respiratory Syncytial Virus Infection : Past , Present and Future

  2012cites this paper
• Nanobodies®: new ammunition to battle viruses.

  2011cites this paper
• Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis

  2011cites this paper
• Treatment of Respiratory Syncytial Virus Infection: Past, Present and Future

  2011cites this paper
• Inhibition of Respiratory Syncytial Virus In Vitro and In Vivo by the Experimental Immunosuppressive Agent Leflunomide

  2010cites this paper
• A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus.

  2010cites this paper
• Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab.

  2008cites this paper
• Enhancement of Mucosal and Cellular Immune Response in Mice by Vaccination with Respiratory Syncytial Virus DNA Encapsulated with Transfersome

  2008cites this paper
• Pneumovirus infection and effects on dendritic cells of mice

  2008cites this paper
• Immunopathology of RSV infection: prospects for developing vaccines without this complication

  2007cites this paper
• The antiviral activity of antibodies in vitro and in vivo

  2004cites this paper
• against Respiratory Syncytial Virus Disease by Using Standard Intravenous Immune Globulin

  2003cites this paper
• Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity

  2002cites this paper
• Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines.

  2001cites this paper
• Use of Intravenous Immunoglobulins for Prophylaxis or Treatment of Infectious Diseases

  2001cites this paper
• Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins

  2001cites this paper
• Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation – a compassionate use experience

  2000cites this paper
• Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

  2000cites this paper
• Human humoral irnrnunity to Respiratory Syncytial Virus : Correlates of disease severity and protection BY

  1999cites this paper
• Novel Therapeutics from Modern Biotechnology

  1999cites this paper
• Prophylaxis with respiratory syncytial virus F-specific humanized monoclonal antibody delays and moderately suppresses the native antibody response but does not impair immunity to late rechallenge.

  1999cites this paper
• Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment

  1999cites this paper
• SB 209763: A Humanized Monoclonal Antibody for the Prophylaxis and Treatment of Respiratory Syncytial Virus Infection

  1999cites this paper
• Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein.

  1998cites this paper
• Viral pneumonia in children

  1998cites this paper
• Sustaining membership lecture award. Dogma, the shade that blinds.

  1998cites this paper
• Respiratory syncytial virus infection in pediatric patients

  1998cites this paper
• Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children.

  1997cites this paper
• Antibody-based therapies for infectious diseases : renaissance for an abandoned arsenal?

  1997cites this paper
• Respiratory syncytial virus-immunoglobulin intravenous (RSV-IGIV) for respiratory syncytial viral infections: part I.

  1997cites this paper
• Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.

  1997cites this paper
• Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.

  1997cites this paper
• Reducing the morbidity of lower respiratory tract infections caused by respiratory syncytial virus: still no answer.

  1997cites this paper
• [Respiratory syncytial viruses: pathogenesis, immunology and disease prevention].

  1997cites this paper
• Community Respiratory Virus Infections in Immunocompromised Patients with Cancer

  1997cites this paper
• Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections

  1997cites this paper
• Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation.

  1996cites this paper
• Nosocomial viral pneumonia in the intensive care unit.

  1995cites this paper
• Evaluation of the Protective Efficacy of Reshaped Human Monoclonal Antibody RSHZ19 against Respiratory Syncytial Virus in Cotton Rats

  1995cites this paper
• Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections

  1995cites this paper
• Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.

  1995cites this paper
• Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.

  1995cites this paper
• Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin.

  1995cites this paper
• Therapeutic Antibodies to Microorganisms

  1995cites this paper
• Clinical immunology and infectious diseases.

  1994cites this paper
• Viral infections of the respiratory tract: prevention and treatment.

  1994cites this paper
• The genetic engineering of monoclonal antibodies.

  1994cites this paper
• Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice

  1994cites this paper
• Immunoprophylaxis and Immunotherapy of Respiratory Syncytial Virus–Infected Mice with Respiratory Syncytial Virus–Specific Immune Serum

  1993cites this paper
• Immunoprophylaxis and immunotherapy: role in the prevention and treatment of repiratory syncytial virus.

  1993cites this paper
• Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin

  1993cites this paper
• Antigenic diversity of respiratory syncytial viruses and its implication for immunoprophylaxis in ruminants.

  1993cites this paper
• Immunoglobulin therapy in older infants and children.

  1992cites this paper
• Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract.

  1992cites this paper
• Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity.

  1992cites this paper
• Approaches to immunization against respiratory syncytial virus.

  1992cites this paper
• Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small-particle aerosol.

  1992cites this paper
• The respiratory syncitial virus and its role in acute bronchiolitis

  1992cites this paper
• Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay.

  1992cites this paper
• Respiratory syncytial virus: babies and antibodies.

  1992cites this paper
• Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention.

  1992cites this paper
• Bovine respiratory syncytial virus-specific immune responses in cattle following immunization with modified-live and inactivated vaccines. Analysis of the specificity and activity of serum antibodies.

  1992cites this paper
• Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group

  1991cites this paper
• Historic aspects of intravenous immunoglobulin therapy

  1991cites this paper
• Immunoglobulin treatment and prophylaxis in the neonate

  1991cites this paper
• Vaccination against respiratory syncytial virus: problems and progress.

  1991cites this paper
• Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells

  1991cites this paper
• Passive immunization for the protection of infants and young children from respiratory infection by respiratory syncytial virus

  1991cites this paper
• Immunobiology of Paramyxoviruses

  1991cites this paper
• Reshaping a Human Monoclonal Antibody to Inhibit Human Respiratory Syncytial Virus Infection in Vivo

  1991cites this paper
• Humanised monoclonal antibody to respiratory syncytial virus.

  1991cites this paper
• Mechanism of antibody-mediated viral clearance in immunotherapy of respiratory syncytial virus infection of cotton rats

  1990cites this paper
• Immunoprophylaxis of infections with respiratory syncytial virus: observations and hypothesis.

  1990cites this paper
• The Envelope Proteins from Purified Respiratory Syncytial Virus Protect Mice from Intranasal Virus Challenge

  1989cites this paper
• Effect of breast feeding on the development of anti-idiotype antibody response to F glycoprotein of respiratory syncytial virus in infant mice after post-partum maternal immunization.

  1989cites this paper
• The effect of foster feeding and bottle feeding expressed breast-milk on the susceptibility of guinea-pig infants to influenza virus.

  1989cites this paper
• Detection, pathogenesis, and therapy of respiratory syncytial virus infections

  1988cites this paper
• Respiratory syncytial virus infection and the immunocompromised host

  1988cites this paper
• Perspectives in the Use of Antiviral Agents for Prevention and Treatment of Respiratory Virus Infections

  1988cites this paper
• Therapeutic uses of intravenous gammaglobulin for pediatric infections.

  1988cites this paper
• Neonatal sepsis: the potential for immunotherapy.

  1988cites this paper
• Human gamma globulins as therapeutic agents.

  1988cites this paper